« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 3
, Pages 275-283
, March 2006
Peritransplantation Vaccination with Chaperone-Rich Cell Lysate Induces Antileukemia Immunity
References
- . Transplantation for chronic myelogenous leukemia: yes, no, maybe so. An Oregon perspective . Bone Marrow Transplant . 2003;32:459–469
- . Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia . Hematol Oncol Clin North Am . 2004;18:685–702
- Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation . Br J Haematol . 2000;110:217–222
- Autologous transplants for chronic myelogenous leukaemia (results from eight transplant groups) . Lancet . 1994;343:1486–1488
- Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML . Blood . 1994;83:3068–3076
- . Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy . Int Immunopharmacol . 2003;3:1121–1143
- Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice . Blood . 2001;98:1852–1857
- . Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells . Biol Blood Marrow Transplant . 2004;10:524–533
- . Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery . Proc Natl Acad Sci U S A . 2002;99:931–936
- Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma . Bone Marrow Transplant . 2000;25:1105–1108
- Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor . Lancet . 1995;345:1016–1020
- Immunotherapy of established tumors using bone marrow transplantation with antigen gene–modified hematopoietic stem cells . Nat Med . 2003;9:952–958
- . Active immunization of murine allogeneic bone marrow transplant donors with B-cell tumor-derived idiotype (a strategy for enhancing the specific antitumor effect of marrow grafts) . Blood . 1996;87:3053–3060
- . Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma (active immunization with tumor-derived idiotypic immunoglobulin) . Blood . 1990;76:2411–2417
- . Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity . Blood . 2003;101:245–252
- . Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines . Cancer Immunol Immunother . 2000;49:476–484
- . Immunoprotective activities of multiple chaperone proteins isolated from murine B-cell leukemia/lymphoma . Clin Cancer Res . 2000;6:909–915
- . Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers . Cancer Immunol Immunother . 2003;52:226–234
- . Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity . Blood . 2003;101:4485–4491
- . Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells . Blood . 2005;105:2016–2022
- . CTLs specific for bcr-abl joining region segment peptides fail to lyse leukemia cells expressing p210 bcr-abl protein . J Immunother . 1998;21:257–268
- . Establishment and characterization of BALB/c lymphoma lines with B cell properties . J Immunol . 1979;122:549–554
-
.
Nonparametric estimation from incomplete observations
.
J Am Stat Assoc
. 1958;53:457–481
-
.
Asymptotically efficient rank invariant procedures
.
J R Stat Soc
. 1972;135:457–481
- Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice . Cancer Immunol Immunother . 2001;50:31–40
- . Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia . Int J Cancer . 2004;110:251–259
- Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice . Bone Marrow Transplant . 2000;26:1211–1216
- . Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy . J Immunol . 2004;172:3462–3468
- . Eukaryotic heat shock proteins as molecular links in innate and adaptive immune responses (Hsp60-mediated activation of cytotoxic T cells) . Int Immunol . 2001;13:1121–1127
- . Activation of natural killer cells by heat shock protein 70 . Int J Hyperthermia . 2002;18:576–585
- . Roles of heat-shock proteins in innate and adaptive immunity . Nat Rev Immunol . 2002;2:185–194
- Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells . Exp Hematol . 1999;27:1627–1636
- . Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response . Cell Stress Chaperones . 1998;3:6–11
- . The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells . J Immunol . 2004;172:972–980
- Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice . Exp Hematol . 1996;24:1416–1422
- . Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing . J Immunol . 1996;156:4609–4616
- . Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution . Eur J Immunol . 2003;33:2123–2132
- Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice (implications for strategies of chemoimmunotherapy of cancer) . Blood . 2000;95:2024–2030
- Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen . Bone Marrow Transplant . 2001;28:243–249
- . Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation . Blood . 1991;77:2515–2523
- Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation . Hematology . 2002;7:157–164
- . Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines . Blood . 2000;95:3011–3019
- . Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease . Cancer Res . 2000;60:5797–5802
PII: S1083-8791(06)00038-3
doi: 10.1016/j.bbmt.2006.01.001
© 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 3
, Pages 275-283
, March 2006
